Yan (Ann) Xing, MS, MD
Article
Statin Use and Risk of HCC, Hepatic Decompensation, and Liver Fibrosis in Patients with Chronic Liver Disease
December 1, 2025
CLINICAL QUESTION: Does statin use lower the risk of hepatocellular carcinoma (HCC) and hepatic decompensation in patients with chronic liver disease by mitigating liver fibrosis...